Overview
Campomelic dysplasia (also known as campomelic syndrome or camptomelic dysplasia) is a rare, severe skeletal disorder caused by mutations in the SOX9 gene located on chromosome 17q24. The term 'campomelic' derives from the Greek words for 'bent limb,' reflecting one of the hallmark features of this condition — bowing of the long bones, particularly the tibiae and femora. The disorder affects multiple body systems including the skeletal system, respiratory system, and reproductive system. Key skeletal features include shortening and bowing of the lower limbs, hypoplastic scapulae, eleven pairs of ribs, a bell-shaped narrow thorax, cervical spine abnormalities, and talipes equinovarus (clubfoot). Craniofacial features include a flat face, micrognathia (small jaw), cleft palate, and a large head with a prominent forehead. A distinctive and clinically significant feature is that approximately two-thirds of 46,XY individuals with campomelic dysplasia exhibit sex reversal, presenting with female or ambiguous external genitalia due to the critical role of SOX9 in male sex determination. The condition is typically lethal in the neonatal period, with the majority of affected infants dying within the first weeks to months of life, primarily due to respiratory insufficiency caused by a small, poorly developed thoracic cage and tracheobronchomalacia (softening of the airway cartilage). However, long-term survival has been reported in a minority of cases, and these individuals may develop additional features including progressive kyphoscoliosis, short stature, hearing loss, and intellectual disability. There is no cure for campomelic dysplasia. Treatment is supportive and multidisciplinary, focusing on respiratory management (which may include tracheostomy and ventilatory support), orthopedic interventions for skeletal deformities, and appropriate management of sex development differences. Genetic counseling is important for affected families, as most cases arise from de novo (new) mutations, though rare instances of autosomal dominant inheritance from a mildly affected parent have been documented.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Campomelic dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Campomelic dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Campomelic dysplasia.
Community
No community posts yet. Be the first to share your experience with Campomelic dysplasia.
Start the conversation →Latest news about Campomelic dysplasia
No recent news articles for Campomelic dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Campomelic dysplasia
What is Campomelic dysplasia?
Campomelic dysplasia (also known as campomelic syndrome or camptomelic dysplasia) is a rare, severe skeletal disorder caused by mutations in the SOX9 gene located on chromosome 17q24. The term 'campomelic' derives from the Greek words for 'bent limb,' reflecting one of the hallmark features of this condition — bowing of the long bones, particularly the tibiae and femora. The disorder affects multiple body systems including the skeletal system, respiratory system, and reproductive system. Key skeletal features include shortening and bowing of the lower limbs, hypoplastic scapulae, eleven pairs
How is Campomelic dysplasia inherited?
Campomelic dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Campomelic dysplasia typically begin?
Typical onset of Campomelic dysplasia is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Campomelic dysplasia?
15 specialists and care centers treating Campomelic dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.